Friday, July 30, 2021 10:41:05 AM
I am really worry what will happen to our CYDY if this 13 D group will win..
We will be diluted to nothing by buying IncellDx.
And if some don't believe that this is a plan of this group , I will quote couple of statements I heard myself ..
I attended May 6 ( I think it was 6 ) zoom meeting of 13 D group , thinking that before I vote I should know little more about them..
And I was really in shock when few minutes of talking Mr Paul Rosenbaum said.
"We will merge with IncellDx as soon as possible "
And few minutes ago my friend who also listened reminded me that at the end of the same meeting , and at the end of Dr Patterson speech , he said..
"Cytodyne and IncellDx to stratosphere "
And these are not a lies , not my imagination , this meeting I believe was May 6 , 2021 , another about 50 people were there listening..
So all CYDY shareholders need to evaluate , how good for CYDY shareholders it will be to pay maybe 350M-500M or so for IncellDx ,
And then to hope that we will go to stratospher..
And who will be going to this stratoshere , imo only the members of 13D group who are invested in IncellDx..
And it is not all about the money , what they will do later with leronlimab is as important.
These are a true statements , conclusion of course is my opinion.
GLTA real longs.
We will be diluted to nothing by buying IncellDx.
And if some don't believe that this is a plan of this group , I will quote couple of statements I heard myself ..
I attended May 6 ( I think it was 6 ) zoom meeting of 13 D group , thinking that before I vote I should know little more about them..
And I was really in shock when few minutes of talking Mr Paul Rosenbaum said.
"We will merge with IncellDx as soon as possible "
And few minutes ago my friend who also listened reminded me that at the end of the same meeting , and at the end of Dr Patterson speech , he said..
"Cytodyne and IncellDx to stratosphere "
And these are not a lies , not my imagination , this meeting I believe was May 6 , 2021 , another about 50 people were there listening..
So all CYDY shareholders need to evaluate , how good for CYDY shareholders it will be to pay maybe 350M-500M or so for IncellDx ,
And then to hope that we will go to stratospher..
And who will be going to this stratoshere , imo only the members of 13D group who are invested in IncellDx..
And it is not all about the money , what they will do later with leronlimab is as important.
These are a true statements , conclusion of course is my opinion.
GLTA real longs.
Recent CYDY News
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
